130 related articles for article (PubMed ID: 24464432)
1. Development of a cell-based, high-throughput screening assay for ATM kinase inhibitors.
Guo K; Shelat AA; Guy RK; Kastan MB
J Biomol Screen; 2014 Apr; 19(4):538-46. PubMed ID: 24464432
[TBL] [Abstract][Full Text] [Related]
2. The development of ataxia telangiectasia mutated kinase inhibitors.
Andrs M; Korabecny J; Nepovimova E; Jun D; Hodny Z; Moravcova S; Hanzlikova H; Kuca K
Mini Rev Med Chem; 2014; 14(10):805-11. PubMed ID: 25138084
[TBL] [Abstract][Full Text] [Related]
3. Development of a high-content high-throughput screening assay for the discovery of ATM signaling inhibitors.
Bardelle C; Boros J
J Biomol Screen; 2012 Aug; 17(7):912-20. PubMed ID: 22653913
[TBL] [Abstract][Full Text] [Related]
4. The ATM inhibitor KU55933 sensitizes radioresistant bladder cancer cells with DAB2IP gene defect.
Zhang T; Shen Y; Chen Y; Hsieh JT; Kong Z
Int J Radiat Biol; 2015 Apr; 91(4):368-78. PubMed ID: 25585815
[TBL] [Abstract][Full Text] [Related]
5. PTEN enhances G2/M arrest in etoposide-treated MCF‑7 cells through activation of the ATM pathway.
Zhang R; Zhu L; Zhang L; Xu A; Li Z; Xu Y; He P; Wu M; Wei F; Wang C
Oncol Rep; 2016 May; 35(5):2707-14. PubMed ID: 26986476
[TBL] [Abstract][Full Text] [Related]
6. Investigation of switch from ATM to ATR signaling at the sites of DNA damage induced by low and high LET radiation.
Saha J; Wang M; Cucinotta FA
DNA Repair (Amst); 2013 Dec; 12(12):1143-51. PubMed ID: 24238855
[TBL] [Abstract][Full Text] [Related]
7. Oxidative DNA damage is involved in ochratoxin A-induced G2 arrest through ataxia telangiectasia-mutated (ATM) pathways in human gastric epithelium GES-1 cells in vitro.
Cui J; Liu J; Wu S; Wang Y; Shen H; Xing L; Wang J; Yan X; Zhang X
Arch Toxicol; 2013 Oct; 87(10):1829-40. PubMed ID: 23515941
[TBL] [Abstract][Full Text] [Related]
8. Persistence of unrepaired DNA double strand breaks caused by inhibition of ATM does not lead to radio-sensitisation in the absence of NF-κB activation.
Veuger SJ; Durkacz BW
DNA Repair (Amst); 2011 Feb; 10(2):235-44. PubMed ID: 21144805
[TBL] [Abstract][Full Text] [Related]
9. Effect of ATM and HDAC Inhibition on Etoposide-Induced DNA Damage in Porcine Early Preimplantation Embryos.
Wang H; Luo Y; Lin Z; Lee IW; Kwon J; Cui XS; Kim NH
PLoS One; 2015; 10(11):e0142561. PubMed ID: 26556501
[TBL] [Abstract][Full Text] [Related]
10. 2-Hydroxyethyl methacrylate-induced apoptosis through the ATM- and p53-dependent intrinsic mitochondrial pathway.
Schweikl H; Petzel C; Bolay C; Hiller KA; Buchalla W; Krifka S
Biomaterials; 2014 Mar; 35(9):2890-904. PubMed ID: 24411679
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologic inhibition of ATR and ATM offers clinically important distinctions to enhancing platinum or radiation response in ovarian, endometrial, and cervical cancer cells.
Teng PN; Bateman NW; Darcy KM; Hamilton CA; Maxwell GL; Bakkenist CJ; Conrads TP
Gynecol Oncol; 2015 Mar; 136(3):554-61. PubMed ID: 25560806
[TBL] [Abstract][Full Text] [Related]
12. DNA-PK inhibition by NU7441 sensitizes breast cancer cells to ionizing radiation and doxorubicin.
Ciszewski WM; Tavecchio M; Dastych J; Curtin NJ
Breast Cancer Res Treat; 2014 Jan; 143(1):47-55. PubMed ID: 24292814
[TBL] [Abstract][Full Text] [Related]
13. Priming phosphorylation of Chk2 by polo-like kinase 3 (Plk3) mediates its full activation by ATM and a downstream checkpoint in response to DNA damage.
Bahassi el M; Myer DL; McKenney RJ; Hennigan RF; Stambrook PJ
Mutat Res; 2006 Apr; 596(1-2):166-76. PubMed ID: 16481012
[TBL] [Abstract][Full Text] [Related]
14. Recently emerging signaling landscape of ataxia-telangiectasia mutated (ATM) kinase.
Farooqi AA; Attar R; Arslan BA; Romero MA; ul Haq MF; Qadir MI
Asian Pac J Cancer Prev; 2014; 15(16):6485-8. PubMed ID: 25169474
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic targeting of a robust non-oncogene addiction to PRKDC in ATM-defective tumors.
Riabinska A; Daheim M; Herter-Sprie GS; Winkler J; Fritz C; Hallek M; Thomas RK; Kreuzer KA; Frenzel LP; Monfared P; Martins-Boucas J; Chen S; Reinhardt HC
Sci Transl Med; 2013 Jun; 5(189):189ra78. PubMed ID: 23761041
[TBL] [Abstract][Full Text] [Related]
16. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.
De Bacco F; Luraghi P; Medico E; Reato G; Girolami F; Perera T; Gabriele P; Comoglio PM; Boccaccio C
J Natl Cancer Inst; 2011 Apr; 103(8):645-61. PubMed ID: 21464397
[TBL] [Abstract][Full Text] [Related]
17. Constitutive phosphorylation of ATM in lymphoblastoid cell lines from patients with ICF syndrome without downstream kinase activity.
Goldstine JV; Nahas S; Gamo K; Gartler SM; Hansen RS; Roelfsema JH; Gatti RA; Marahrens Y
DNA Repair (Amst); 2006 Apr; 5(4):432-43. PubMed ID: 16426903
[TBL] [Abstract][Full Text] [Related]
18. Replication protein A2 phosphorylation after DNA damage by the coordinated action of ataxia telangiectasia-mutated and DNA-dependent protein kinase.
Wang H; Guan J; Wang H; Perrault AR; Wang Y; Iliakis G
Cancer Res; 2001 Dec; 61(23):8554-63. PubMed ID: 11731442
[TBL] [Abstract][Full Text] [Related]
19. Radioprotection by hymenialdisine-derived checkpoint kinase 2 inhibitors.
Nguyen TN; Saleem RS; Luderer MJ; Hovde S; Henry RW; Tepe JJ
ACS Chem Biol; 2012 Jan; 7(1):172-84. PubMed ID: 22004065
[TBL] [Abstract][Full Text] [Related]
20. Functional characterization connects individual patient mutations in ataxia telangiectasia mutated (ATM) with dysfunction of specific DNA double-strand break-repair signaling pathways.
Keimling M; Volcic M; Csernok A; Wieland B; Dörk T; Wiesmüller L
FASEB J; 2011 Nov; 25(11):3849-60. PubMed ID: 21778326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]